News tagged with 'Cerivastatin'

Out-of-court Baycol settlements are on the rise despite Bayer Corporation's victories in the first two cases to go to trial. Bayer announced Wednesday that the pharmaceutical maker has settled 785 Baycol lawsuits (27 involving deaths from the drug) at a cost of $240 million. At the time of Bayer's successful first tr

Less than a month after Bayer Corporation was found not liable in the first lawsuit to go to trial over the cholesterol medication Baycol, a Mississippi court cleared the pharmaceutical maker in the second U.S. case to reach a jury. The lawsuit involved a woman in her 70s who alleged Baycol use led to debilitating m

A Corpus Christi, Texas jury Tuesday found Bayer Corporation not liable in the first lawsuit to go to trial over the cholesterol-lowering drug Baycol. The suit, filed by 82-year-old Hollis Haltom, was seeking $560 million in damages. During the trial, plaintiff attorneys argued that Baycol caused Haltom to develop

Jurors in Corpus Christi, Texas began deliberations Friday after hearing three weeks of testimony in the first lawsuit to go to trial over Bayer Corporation's withdrawn cholesterol drug Baycol. The plaintiff, 82-year-old retired engineer Hollis Haltom, alleges he began suffering from rhabdomyolysis , a severe muscle

Bayer Corporation stockholders, angered over the company's alleged misrepresentation of its withdrawn cholesterol drug Baycol, have filed a securities and investment fraud lawsuit against the pharmaceutical maker. In the claim, shareholders, seeking damages for the fall in the company's share price, allege Bayer viola

Lawyers arguing the first lawsuit to go to trial over the withdrawn cholesterol medication Baycol presented closing arguments Wednesday in Corpus Christi, Texas. Analysts have been keeping a close eye on the trial since it began last February, as many legal experts believe it may set a precedent for future Baycol li

A highly publicized trial involving the cholesterol-lowering drug Baycol continued in Corpus Christi, Texas this week with plaintiff attorneys presenting evidence that showed a mounting unease among Bayer executives even as they continued to market the controversial medication. According to memos and e-mails submitted

Plaintiff attorneys arguing the first lawsuit to go to trial over the withdrawn cholesterol drug Baycol are reportedly seeking $500 million in punitive damages. According to a German newspaper, the amount is in addition to compensation of around $100 million already demanded in the case. The suit , which is ong

Bayer Corporation's lead attorney announced Tuesday that the company was in talks to settle 500 lawsuits over its now-banned cholesterol medication Baycol. Bayer has already settled around 450 claims, at a cost of nearly $125 million. The additional 500 cases involve patients who now suffer from rhabdomyolysis , a s

Bayer Corporation is facing accusations this week that the pharmaceutical giant continued to market its cholesterol-lowering medication Baycol despite the fact company officials knew the drug was causing severe health problems. Newly released documents, reportedly made public by a personal injury attorney involved in

The legal world kept a close eye on Corpus Christi, Texas this week as the first trial in the United States involving the withdrawn cholesterol medication Baycol began. The plaintiff, retired engineer Hollis Haltom, alleges Baycol, which was removed from the U.S. market in August 2001, caused him to develop rhabdomyo

Pharmaceutical maker Bayer announced this week that it is facing 7,400 lawsuits stemming from the August 2001 recall of the cholesterol-lowering medication Baycol, up from 5,700 in November 2002. A spokesperson for Bayer said the company has settled 400 of those suits but refused to disclose the amount of the settleme

German pharmaceutical manufacturer Bayer AG announced Monday that the company is facing an additional 1,500 lawsuits over its cholesterol-lowering medication Baycol. A spokesperson for the company, which had previously maintained that only 2,000 claims were pending, said the majority of the now 3,500 lawsuits are in t

The chief executive officer of Bayer AG told the German business magazine WirtschaftsWoche in a recent interview that the company would be willing to settle individual lawsuits involving the now-banned cholesterol drug Baycol. CEO Werner Wenning told the magazine that Bayer was ready to settle in individual cases but

Although it has been seven months since Bayer AG officially halted production of Baycol due to the alarming number of serious side effects associated with the drug, lawsuits are still being filed in court. Four former Baycol users who claim they suffered serious health problems after using the drug filed suit in state